Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.

Also called NCT03667677

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 256 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03667677
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03667677. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-01 (anticipated); primary completion 2020-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
Condition
Hypertension
Condition
Anxiety
Intervention (Drug)
Tandospirone + Amlodipine
Intervention (Drug)
Tandospirone placebo + Amlodipine
Intervention (Drug)
Tandospirone + Amlodipine placebo
Intervention (Drug)
Tandospirone placebo + Amlodipine placebo
Lead sponsor
Chongqing Medical University (class: other)

Record details

Record id
cardio:ct-nct03667677
Content hash
36dfc72cf7f40b199aae09271b4f79f0a903dcddb8c43660847eba4d4a0e2d57